PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

Subikksha Saravanan,R. Rengaswamy,G. Narula,S. Bakhshi,R. Seth,Nandana Das,M. Gogoi,S. Banavali,Prasanth Srinivasan,G. Das,T. Balaji,Shekar Krishnan,Vaskar Saha,V. Ramshankar,V. Radhakrishnan

Published 2026 in JCO Clinical Cancer Informatics

ABSTRACT

PURPOSE The Pediatric Relapse Prediction and Risk Evaluation for Acute Lymphoblastic Leukemia (PREPARE-ALL) tool aims to predict relapse in pediatric ALL by integrating clinical expertise with artificial intelligence and machine learning (ML), particularly Extreme Gradient Boosting (XGBoost). PREPARE-ALL demonstrates that multicenter, protocol-driven clinical and laboratory data can be used through ML to generate reproducible relapse predictions with greater sensitivity than individual clinician assessments. METHODS PREPARE-ALL was developed using data from the ICiCLe ALL-14 pretrial cohort across five centers, incorporating 33 clinical and laboratory features. RESULTS Among 2,252 patients enrolled in the study, 565 (25.1%) relapsed. Using an 80:20 train-test split, XGBoost achieved a sensitivity of 68.5% (245/447 relapses detected). Additional metrics included a positive predictive value of 31.3%, a negative predictive value of 82.8%, an accuracy of 54.8%, and a specificity of 50.3%. Key predictors of relapse included high hyperdiploidy and BCR-ABL1 fusion positive, positive measurable residual disease status at the end of induction, sex, age, highest presenting WBC, and final risk group. Three clinicians scored the validation data set; the developed model achieved a higher recall (68.5%) compared with clinical judgment (approximately 31%-36%). CONCLUSION PREPARE-ALL identifies twice as many relapses as clinicians and serves as a practical decision-support tool for early relapse triage and treatment planning, enabling timely therapeutic adjustments and improved outcomes in pediatric ALL.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-19 of 19 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1